TrAMPoline Pharma, Inc.

TrAMPoline Pharma, Inc. is a biotechnology company focused on developing personalized cell therapies for solid tumor cancers. TrAMPoline Pharma, Inc. is dedicated to reviving the patient’s immune system to destroy cancer. Their lead therapeutic candidate, MightyTIL™, uses proprietary technology to produce engineered Tumor Infiltrating Lymphocytes (TIL), demonstrating significantly enhanced anti-tumor activity versus unmodified TIL in multiple animal models.

Located in Aurora, CO, TrAMPoline Pharma, Inc. operates primarily from its main address at 12635 E Montview Blvd., Suite 125, Aurora, CO 80045, US. TrAMPoline Pharma, Inc. is at the forefront of innovative approaches to cancer treatment, aiming to provide effective and lasting solutions.

TrAMPoline Pharma, Inc. is committed to advancing the field of oncology through cutting-edge research and development. We invite the management of TrAMPoline Pharma, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial reach and development.